Items where Author is "Mathieu, MG"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 10.

Journal article

HARNER-FOREMAN, N., VADAKEKOLATHU, J., LAVERSIN, S.A., MATHIEU, M.G., REEDER, S., POCKLEY, A.G., REES, R.C. and BOOCOCK, D.J., 2017. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. Scientific Reports, 7, p. 40633. ISSN 2045-2322

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-a-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death and Disease, 5 (2). ISSN 2041-4889

MATHIEU, M.G., MILES, A.K., AHMAD, M., BUCZEK, M.E., POCKLEY, A.G., REES, R.C. and REGAD, T., 2014. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell Death & Disease, 5 (2). ISSN 2041-4889

LINLEY, A.J., MATHIEU, M.G., MILES, A.K., REES, R.C., MCARDLE, S.E.B. and REGAD, T., 2012. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tunor cell proliferation in vivo. Journal of Biological Chemistry, 287 (17), pp. 13633-13643.

MATHIEU, M.G., LINLEY, A.J., REEDER, S.P., BADOUAL, C., TARTOUR, E., REES, R.C. and MCARDLE, S.E.B., 2010. HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer Immunity, 10, p. 2.

LINLEY, A.J., MILES, A.K., AL-FAWAZ, M., LU, C., MCARDLE, S.E.B., REES, R.C. and MATHIEU, M.G., 2009. Non-X-linked cancer/testis antigens: identification, expression profile and immunogenicity [review]. Current Trends in Immunology.

RILEY, C.L., MATHIEU, M.G., CLARK, R.E., MCARDLE, S.E. and REES, R.C., 2009. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? Cancer Immunology Immunotherapy, 58 (9), pp. 1489-1499.

MATHIEU, M.G., KNIGHTS, A.J., PAWELEC, G., RILEY, C.L., WERNET, D., LEMONNIER, F.A., STRATEN, P.T., MUELLER, L., REES, R.C. and MCARDLE, S.E., 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

ASSUDANI, D.P., HORTON, R.B.V., MATHIEU, M.G., MCARDLE, S.E. and REES, R.C., 2007. The role of CD4(+) T cell help in cancer immunity and the formulation of novel cancer vaccines. Cancer Immunology Immunotherapy, 56 (1), pp. 70-80. ISSN 0340-7004

Chapter in book

REGAD, T. and MATHIEU, M.G., 2014. Cancer Stem Cells (CSCs) and Epithelial-to-Mesenchymal Transition (EMT): tumor cell plasticity challenges immunotherapy. In: R.C. REES, ed., Tumor immunology and immunotherapy. Oxford: Oxford University Press. ISBN 9780199676866

This list was generated on Tue Nov 21 13:32:39 2017 UTC.